Telomir PharmaceuticalsTELO
13F holders, Q2 2026 (June 30)33holders +6
11new positions
5sold out
1famous investor
$1.27avg. 13F price*
At the end of Q2 2026, 33 institutions reported holding Telomir Pharmaceuticals Inc. (TELO) in their 13F filings, up 6 from Q1 2026. 11 opened new positions and 5 sold out. The largest holders were Vanguard Capital Management LLC ($2.1M), Geode Capital Management, LLC ($434K) and BlackRock, Inc. ($359K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Telomir Pharmaceuticals Inc.
- CUSIP
- 87975F104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $176K |
| Exits | 5 | $295K |
All 13F filers, Q1 2026 → Q2 2026: 973,585 shares bought and 236,713 shares sold, net +736,872 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Vanguard Capital Management LLC | 0.00% | Add +62.1% | 1,613,639 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +36.0% | 338,875 | $434K |
| BlackRock, Inc. | 0.00% | Reduce -3.0% | 280,472 | $359K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +66.2% | 225,304 | $288K |
| Northern Trust Corp. | 0.00% | Add +47.0% | 61,532 | $79K |
| State Street Corp. | 0.00% | No change | 58,600 | $75K |
| Bank of New York Mellon Corp | 0.00% | No change | 51,454 | $66K |
| Captrust Financial Advisors | 0.00% | New | 51,194 | $66K |
| Osaic Holdings, Inc. | 0.00% | Add +15.9% | 41,490 | $53K |
| World Investment Advisors | 0.00% | No change | 37,037 | $48K |
| OneDigital Investment Advisors LLC | 0.00% | No change | 23,000 | $29K |
| Qube Research & Technologies Ltd | 0.00% | New | 21,792 | $28K |
| Praetorian Wealth Management, Inc. | 0.00% | No change | 20,000 | $26K |
| Virtu Financial LLC | 0.00% | New | 17,546 | $22K |
| Vestmark Advisory Solutions, Inc. | 0.00% | Add +3.8% | 13,600 | $17K |
| Citadel Advisors | 0.00% | New | 13,266 | $17K |
| Morton Capital Management LLC | 0.00% | No change | 12,658 | $16K |
| Two Sigma Securities, LLC | 0.00% | New | 12,616 | $16K |
| Clearstead Advisors, LLC | 0.00% | No change | 12,530 | $16K |
| NorthCrest Asset Manangement, LLC | 0.00% | New | 12,119 | $15K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 11,000 | $14K |
| Regions Financial Corp. | 0.00% | No change | 10,638 | $14K |
| UBS Group AG | 0.00% | Reduce -13.6% | 7,959 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,920 | $10K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 6,552 | $8K |
| Royal Bank of Canada | 0.00% | New | 754 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 600 | $744 |
| Barclays PLC | 0.00% | New | 553 | $708 |
| BNP Paribas Financial Markets | 0.00% | Reduce -2.4% | 201 | $257 |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $151 |
| Morgan Stanley | 0.00% | New | 5 | $6 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $5 |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 12,119 | $0 |
"% of holder's portfolio" is TELO's weight in each manager's 13F, not the share of Telomir Pharmaceuticals Inc. the manager owns.